Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McMaster University
$35,000.00
Adoptive transfer of cytokine-induced killers with chimeric antigen receptors for cancer immunothereapy
FY 2012-13
Summary
Cancer is currently a leading cause of death throughout many parts of the world. Despite great advancements in the treatment of primary tumours through the use of surgery, radiation, and chemotherapies, metastatic cancers continue to present a significant problem, as conventional therapies are largely ineffective against systemic disease. A particularly promising area of cancer treatment development is immunotherapy, which employs a patient's own immune system to attack cancer cells. This is of particular interest for metastatic cancers, as immune cells are able to circulate freely throughout the body, and have the potential to locate and clear these metastases. We propose to make these immune cells even more effective by causing them to recognize and react to specific targets found only on tumour cells. With this method, we and others have demonstrated that it is possible to produce robust immunity against the tumour while leaving healthy tissues unscathed. As an alternative to, or in conjunction with, conventional cancer therapies, our research has the potential to effectively treat both primary and metastatic disease, while preserving the integrity of normal, healthy tissues. As a result, our research could lead to an increase in patient survival and quality of life during cancer treatment.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
283873
Name
Nolte SARA M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Adoptive transfer of cytokine-induced killers with chimeric antigen receptors for cancer immunothereapy
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$35,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Adoptive Cell Transfer; Breast Cancer; Chimeric Antigen Receptor; Cytokine-Induced Killers; Mouse Models; Oncolytic Virus; Solid Tumours
Abstract
Cancer is currently a leading cause of death throughout many parts of the world. Despite great advancements in the treatment of primary tumours through the use of surgery, radiation, and chemotherapies, metastatic cancers continue to present a significant problem, as conventional therapies are largely ineffective against systemic disease. A particularly promising area of cancer treatment development is immunotherapy, which employs a patient's own immune system to attack cancer cells. This is of particular interest for metastatic cancers, as immune cells are able to circulate freely throughout the body, and have the potential to locate and clear these metastases. We propose to make these immune cells even more effective by causing them to recognize and react to specific targets found only on tumour cells. With this method, we and others have demonstrated that it is possible to produce robust immunity against the tumour while leaving healthy tissues unscathed. As an alternative to, or in conjunction with, conventional cancer therapies, our research has the potential to effectively treat both primary and metastatic disease, while preserving the integrity of normal, healthy tissues. As a result, our research could lead to an increase in patient survival and quality of life during cancer treatment.
Competitiondate
201210
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nolte, SARA M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $35,000~ $0~